Screening for cancer in Taiwan

Israel’s BioView has sold its first Circulating Tumor Cells (CTC) screening device to Taiwan Academia Sinica for NIS 600,000. BioView’s system distinguishes healthy cells from tumour cells and can diagnose tumours from very small samples.

This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published.